Solid Biosciences (SLDB)
(Real Time Quote from BATS)
$7.81 USD
-0.83 (-9.61%)
Updated Aug 2, 2024 03:00 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.68 |
EPS Last Quarter | -0.64 |
Last EPS Surprise | -12.28% |
ABR | 1.00 |
Earnings ESP
|
-1.72% |
---|---|
Current Year | -2.71 |
Next Year | -2.78 |
EPS (TTM) | -3.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 8.09M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.68 | -0.71 | -2.71 | -2.78 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.69 | -0.72 | -2.79 | -2.88 |
High Estimate | -0.65 | -0.67 | -2.58 | -1.97 |
Low Estimate | -0.72 | -0.78 | -2.87 | -3.63 |
Year ago EPS | -1.25 | -1.05 | -4.83 | -2.71 |
Year over Year Growth Est. | 45.60% | 32.38% | 43.89% | -2.65% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 2 |
Down Last 60 Days | 1 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.68 | -0.71 | -2.71 | -2.78 |
7 Days Ago | -0.68 | -0.71 | -2.71 | -2.78 |
30 Days Ago | -0.66 | -0.68 | -2.64 | -2.60 |
60 Days Ago | -0.66 | -0.69 | -2.65 | -2.60 |
90 Days Ago | -0.61 | -0.66 | -2.64 | -2.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.69 | -0.72 | -2.79 | -2.43 |
Zacks Consensus Estimate | -0.68 | -0.71 | -2.71 | -2.78 |
Earnings ESP | -1.72% | -1.17% | -2.90% | 12.87% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.64 | -1.00 | -1.05 | -1.25 | NA |
Estimate | -0.57 | -1.01 | -1.20 | -1.52 | NA |
Difference | -0.07 | 0.01 | 0.15 | 0.27 | 0.09 |
Surprise | -12.28% | 0.99% | 12.50% | 17.76% | 4.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more